NCT00719199 - Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

August 31, 2011

Conditions

Colorectal Cancer

Interventions

DRUG

IMO-2055

SC weekly injections

DRUG

Cetuximab

given weekly through intravenous administration. Cycle 1 Day 1 dose given at 400mg/m2, all subsequent doses given at 250 mg/m2.

DRUG

FOLFIRI

Given day 1 of each cycle

Trial Locations (5)

Vanderbilt-Ingram Cancer Center, Nashville

Cancer Therapy & Research Center, San Antonio

Georgetown University Lombardi Cancer Center, Washington D.C.

Dana-Farber Cancer Institute, Boston

Cancer Therapy and Research Center, San Antonio